Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2022-08-31 | New | Yet to Sell | $0 | Debt Only | 06b | SEC link |
| 2022-08-02 | New | $400,000 | $400,000 | Other | 06b | SEC link |
| 2015-04-02 | New | $200,000 | $200,000 | Equity Only | 06b | SEC link |
| 2013-09-25 | Amended | $2,892,750 | $2,692,750 | Equity Only | 06b | SEC link |
| 2012-11-15 | Amended | $200,000 | $0 | Equity Only | 06 | SEC link |
| 2012-10-02 | New | $200,000 | $200,000 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Peter Aronstam | Executive |
| Vincent Butta | Director |
| Angus Dalgleish | Executive |
| Cynthia Douglas | Executive |
| Seth Elliott | Executive |
| Glen Farmer | Executive |
| Joseph Fortunak | Executive |
| Noreen Griffin | Executive |
| Gloria Herndon | Director |
| Roscoe Moore | Director |
| Christopher Pearce | Director |
| Kevin Phelps | Director |
| Nicholas Plotnikoff | Director |
| Clifford Selsky | Director |
| Fengpin Shan | Director, Executive |
| Fengping Shan | Executive |
| Edward Teraskiewicz | Director |
| Robert Wilson | Director |
| Stephen Wilson | Director, Executive |
| Kelly Wilson | Executive |
| Eugene Youkilis | Director |